Dr Kotwal is a clinical nephrologist at the Prince of Wales Hospital in Sydney; Program Head of the Renal and Metabolic Division at The George Institute for Global Health and a Conjoint Senior Lecturer at UNSW. Her research interests include novel and pragmatic clinical trials and she is passionate about increasing clinical trial access for patients with kidney disease and personalised medicine. Dr Kotwal is the Academic Project Director for the GKPTN and the principal investigator for the Glomerular Disease Registry and Biobank in Sydney. She has expertise in translating research into clinical practice and in-depth knowledge of statistical techniques, epidemiology and clinical trial design.

Dr Menglu Ouyang is a research fellow at The George Insititute for Global Health and Conjoint Lecturer at UNSW. Her research field is in stroke, including acute care, clinical management, health system and implementation science. She has extensive experience in secondary analysis in large international clinical trials and implementation research. Her research contributes to filling the knowledge gap in stroke clinical guidelines development, informs implementation strategies and supports promoting the care embedded in existing processes in low- and middle-income countries.

She is the leading investigator for the process evaluation alongside the large international trials funded by MRC and NHMRC, to explore the feasibility, acceptability and implementation of evidence-based care. She also chairs the monthly Process Evaluation/Health System Research Seminar at The George Institute. She is in the UNSW Cardiac, Vascular, Metabolic Medicine Early Career Researcher Committee and the editor board of Cerebrovascular Diseases and Frontiers Public Health.

Ben is a doctor from the UK and Advanced Trainee in nephrology who is completing a PhD at the George Institute. The focuses of the PhD is improving the outcomes and economics of treating chronic kidney disease with a particular interest in low-and-middle-income countries. Ben is also involved with the Affordable Dialysis Project – an initiative run by The George Institute to develop a system that can provide low cost dialysis to those who currently cannot afford it. He works as clinical advisor for this project.

Associate Professor Clare Arnott is Director of the Cardiovascular Program at The George Institute for Global Health and Associate Professor in Medicine at UNSW Sydney. 

A/Prof Arnott’s research focuses on women’s heart disease, heart failure, cardiovascular imaging, and cardio-kidney-metabolic (CKM) disease. Her work has significantly influenced national health policy and clinical management. 

As an experienced clinical trialist and the recipient of $28 million in research funding, A/Prof Arnott is an expert in investigating novel cardiometabolic treatments and pregnancy-related cardiovascular diseases including pre-eclampsia and pulmonary hypertension. 

She is also Pagent Director of Heart Lung Clinical Research at St Vincent's Hospital, Sydney, Director and Founder of the Women’s Heart Clinic at Royal Prince Alfred Hospital, and Senior Staff Specialist Cardiologist at St Vincent’s Hospital and Royal Prince Alfred Hospital, Sydney.

A/Prof Arnott is a Fellow of the Cardiac Society of Australia and New Zealand and the European Society of Cardiology, and member of the ANZACT Steering Committee, as well as serving on the editorial board of Heart, Lung and Circulation. 

Sandhya received her doctoral degree in Social Medicine and Community Health from Jawaharlal Nehru University, New Delhi. Her work with The George Institute's mental health programme involves assessing the effectiveness of technology-enabled delivery of mental health care by primary healthcare workers for depression, suicide and stress among adolescents in urban slum communities in Delhi and Vijayawada.

Her research interest includes developing a gendered understanding and analysis of mental health issues in India. Prior to joining The George Institute, Sandhya was at SAHAYOG as the Assistant Coordinator. 

Professor John A Myburgh AO, is the Director, Professoriate at the George Institute for Global Health.

He is also Professor of Intensive Care Medicine, University of New South Wales and Senior Intensive Care Physician at the St George Hospital, Sydney.

He holds a National Health and Medical Research Council Leadership Investigator Grant Fellowship and an honorary Professorial appointment at the Monash University School of Public Health and Preventive Medicine.

He has an extensive research record of accomplishment over 30 years and is regarded as a national and international expert in catecholamine neurophysiology and pharmacology, trials of clinical management of traumatic brain injury, fluid resuscitation and in the development and co-ordination of over 40 clinical trials in Intensive Care Medicine.

He has published over 275 refereed research publications, (including 12 papers in the New England Journal of Medicine) and 45 book chapters and monographs. His current h-index is 44, calculated from 244 publications in SCOPUS, yielding over 15500 citations, with a citation trajectory of 900 to 2200 citations per annum from 2010 to the present.

He has received over $48M grant funding from the National Health and Medical Research Council. In addition to other national and international grants, total cumulative research funding to the present is over A$87M.

He has delivered over 400 presentations at national and international scientific meetings since 1994, including over 50 plenary presentations at major scientific congresses.

He is a Foundation Member and Past-Chairman of the Australian and New Zealand Intensive Care Society Clinical Trials Group. He was instrumental in the establishment of the Australian and New Zealand Intensive Care Research Centre at the Monash University School of Public Health and Preventive Medicine. 

He has made a substantive contribution to education in Intensive Care Medicine, both at undergraduate and postgraduate levels over the last 25 years. He was instrumental in establishing the College of Intensive Care Medicine, serving as a Fellowship examiner for twelve years, on the Board for ten years and as the first elected President from 2010-2012.

He is a Fellow of the Australian Academy of Health and Medical Science and served on the Council of the World Federation of Societies of Intensive and Critical Care Medicine for six years and as Secretary-General from 2017-2019.

In the 2014 Queen’s Birthday honours, he was made an Officer of the Order of Australia (AO) for distinguished service to medicine as an intensive care medical practitioner, educator and researcher, and as an international innovator in patient management